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Atrial ﬂutter catheter ablation in patients with a normal-size
or mildly enlarged left atrium is associated with a higher
likelihood of persistence of sinus rhythm, improvement of
quality of life and symptoms scores, decreased atrial
ﬁbrillation, and decreased rehospitalization at follow-up.
Because of the higher efﬁcacy and the lower persistence of
atrial ﬂutter and atrial ﬁbrillation than is observed with
conventional medical management, catheter ablation is
considered a ﬁrst-line therapy for atrial ﬂutter.1 Typically,
catheter ablation of atrial ﬂutter is performed via femoral
vein access. In the setting of inferior vena cava obstruction,
there are reports of alternate routes of access, via the right
subclavian and jugular veins and, rarely, the hepatic vein.2,3
The percutaneous transhepatic approach has been described
in pediatric patients,4 and 1 case was found documenting this
approach in adults.3 This case report describes the percuta-
neous transhepatic approach to radiofrequency ablation of a
typical right atrial ﬂutter circuit in a 32-year-old African
American woman.Case description
A 32-year-old African American female patient with a past
medical history of hypertension, congestive heart failure,
paroxysmal atrial ﬁbrillation, mitral regurgitation, and end-
stage renal disease on renal replacement therapy (hemodial-
ysis for 11 years) presented with normal sinus rhythm at the
beginning of her dialysis session. After she developed
symptoms of chest pain, dyspnea, and palpitations 1.5 hours
into the dialysis session, she was transferred to a tertiary careKEYWORDS Atrial ﬂutter; Catheter ablation
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gram (Figure 1A).
On clinical examination, a 2/6 systolic murmur was heard,
and a nonfunctioning left upper-extremity ﬁstula was
observed (Figure 1B). The rest of the physical examination
was unremarkable. The patient had multiple failed dialysis
access points, including those in her bilateral groins, and
current access was through a right-tunneled brachiocephalic
dialysis catheter (Video 1, Video 1 Still). The left innomi-
nate vein and both jugular veins were also chronically
occluded. Echocardiogram demonstrated severe left ventric-
ular systolic dysfunction with an estimated ejection frac-
tion of o20%, severe biatrial dilation, and severe mitral
regurgitation.
The patient had needed repeated hospitalizations for
ventricular rate control in atrial ﬂutter. The only option for
medical therapy for her was amiodarone. Antiarrhythmic
therapy with sotalol and dronedarone were contraindicated
with severe left ventricular systolic dysfunction. It was
unlikely that cardioversion would keep her in sinus rhythm
and, at 32 years of age, she was very likely to develop side
effects from the long-term use of amiodarone. Ablation was
deemed to be the optimal approach in treating her atrial
ﬂutter. She was placed under general anesthesia during the
procedure. Vascular interventional radiology was consulted
for transhepatic venous access, and using computed tomog-
raphy guidance, a 22-gauge Chiba needle was placed into the
right lobe of the liver at the midaxillary line. Two catheters
were used, and they were placed in the coronary sinus and on
the cavotricuspid isthmus for ablation (Figures 2A–2C,
Video 2). Postablation bidirectional conduction block
assessed by pacing the lateral free wall and then recording
at the coronary sinus, as well as pacing the atrium at the
coronary sinus and recording at the lateral free wall should
the activation of atrium on the other side of the block be
delayed, demonstrated that the wave of depolarization
should transmit and travel around the atrium counterclock-
wise to the other side of the block.pen access article under the CC BY-NC-ND license
http://dx.doi.org/10.1016/j.hrcr.2016.01.010
KEY TEACHING POINTS
● Percutaneous transhepatic access can be used in
adult patients to treat a variety of arrhythmias.
● Transhepatic access offers an approach that allows
for greater catheter stability and maneuverability.
● This case study provides an example of the utility
of a transhepatic approach under ﬂuoroscopic
guidance in a patient with end-stage renal disease
and unusable access points.
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isthmus. Postprocedure, sheaths were removed by vascular
interventional radiology with coil embolization of the tracts
(Figure 2D). The patient had no episodes of bleeding, and
she remained in sinus rhythm throughout the rest of her
hospital stay (Figure 1C).Discussion
We report a case of typical right atrial ﬂutter in a female
patient on hemodialysis for end-stage renal disease. Suc-
cessful ablation was achieved in the electrophysiology
laboratory via percutaneous hepatic vein access. This route
was chosen as the patient had multiple failed hemodialysis
access points, including those in her bilateral groins. In
previous studies, a transhepatic approach had been explored
in 2 patients: 1 patient had atrial ﬂutter in the setting of
complex congenital heart disease and the other had atrial
ﬁbrillation with inferior vena cava interruption. TheFigure 1 A: Negative deﬂections in II, III, and aVF (inferior leads) and positi
dependent atrial ﬂutter. B: Left internal jugular and left subclavian veins were th
C: Postprocedure electrocardiogram, which illustrates the termination of atrial ﬂupercutaneous transhepatic approach was successfully
employed in both cases to eliminate atrial arrhythmias3.
The hepatic vein has been used as a long-term access
route for noncardiovascular interventions, including hemo-
dialysis and total parenteral nutrition.5,6 This technique has
also been well documented in pediatric patients for catheter-
ization of the left side of the heart. The anatomical location of
the hepatic vein provides for catheter stability and the large
size of the vessel makes it suitable for introduction of the
sheath required in this procedure. Complications associated
with hepatic vein access for catheter ablation are minimal to
none.3 Use of the hepatic vein has also been reported in cases
of permanent-pacemaker-lead insertion in pediatric patients
with Fontan circulation.7 The complications associated with
a transhepatic approach include hemorrhage, sepsis, throm-
bosis, and pancreatitis.5
The use of a transhepatic approach for catheter ablation
has been previously described in 6 adult patients, both with
and without congenital heart disease.7 Of these patients, 4
had D-transposition of the great vessels and required
systemic arterial circulation to complete a cavotricuspid
isthmus ablation line from the tricuspid valve to the inferior
vena cava. A transhepatic approach is more inferior and
allows for greater maneuverability. However, the site is less
compressible, should hemostasis be required. It is an
approach that can be useful for catheter ablation of different
arrhythmias. This approach, although widely utilized in the
pediatric population, is not as readily used in the adult
population. Careful selection of patients should be done, and
the procedure is preferably approached in a more experi-
enced center, although as demonstrated, it may be used whenve deﬂections in V1 (criteria for ﬂutter) suggesting cavotricuspid isthmus–
e ﬁnal access points still available, and losing this access was undesirable.
tter.
Figure 2 A: Placement of a second sheath with a 0.018 wire through a 22-gauge Chiba needle placed into a superﬁcial hepatic vein via Doppler ultrasound and
guided into the IVC. B: Coils being placed to prevent bleeding complications. C: 9F and 7F sheaths were placed into the right hepatic vein and middle hepatic
vein, respectively, and advanced, as seen, with contrast to the right atrial junction. D: Two coils were placed to prevent peritoneal bleeding. IVC = inferior vena
cava.
243Iqbal et al Transhepatic Ablation of a CTI-Dependent Atrial Flutterother options for access are not available.7 In conclusion, this
case describes a unique approach to a routine procedure and
illustrates that percutaneous transhepatic venous access is a
viable alternative for catheter ablation in the face of difﬁcult
venous access.
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